Crossref
Fake data from trial sites ruin studies, drug firms say
Science · 2026
DOI: 10.1126/science.aef2599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2026. Verfasst von Charles Piller. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Development, Drug Industry, Scientific Misconduct.
Abstract (Originalsprache)
Alzheimer’s drug developer accuses companies it hired of providing “medically impossible” results
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Alzheimer DiseaseDrug DevelopmentDrug IndustryScientific MisconductHumansClinical Trials as TopicUnited StatesAntibodies, Monoclonal, Humanized
Substanzen
aducanumabAntibodies, Monoclonal, Humanized
Zitieren
APA
Piller, C. (2026). Fake data from trial sites ruin studies, drug firms say. Science. https://doi.org/10.1126/science.aef2599
Vancouver
Piller C. Fake data from trial sites ruin studies, drug firms say. Science. 2026. doi:10.1126/science.aef2599
BibTeX
@article{Piller2026,
author = {Piller, Charles},
title = {Fake data from trial sites ruin studies, drug firms say},
journal = {Science},
year = {2026},
doi = {10.1126/science.aef2599}
}
EUVIMED